CAREY STEPHEN P. 4
4 · ANI PHARMACEUTICALS INC · Filed Mar 5, 2026
Insider Transaction Report
Form 4
CAREY STEPHEN P.
SVP & CFO
Transactions
- Exercise/Conversion
Common Stock
2026-03-05$49.51/sh+3,312$163,977→ 192,855 total - Sale
Common Stock
[F1]2026-03-05$75.42/sh−3,312$249,791→ 189,543 total - Sale
Common Stock
2026-03-05$75.56/sh−4,000$302,240→ 185,543 total - Exercise/Conversion
Stock Option (right to buy)
[F2]2026-03-05$49.51/sh−3,312$163,977→ 9,938 totalExercise: $49.51Exp: 2027-03-30→ Common Stock (3,312 underlying)
Footnotes (2)
- [F1]The shares were sold in multiple trades at prices ranging from $75.41 to $75.56. The price reported above reflects the weighted average sales price.
- [F2]25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.
Signature
/s/ Stephen P. Carey, by attorney-in-fact Meredith W. Cook|2026-03-05